Start Date
October 31, 2020
Primary Completion Date
August 30, 2022
Study Completion Date
August 30, 2022
Ixazomib
Ixazomib intravenous injection in combination with reduction chemotherapy.
Hospital Universitario Vall d'Hebron - PPDS, Barcelona
Memorial Sloan Kettering Cancer Center, New York
C.H. Regional Reina Sofia, Córdoba
Hospital Universitario La Paz, Madrid
St Jude Children's Research Hospital, Memphis
University of Mississippi Medical Center, Jackson
Washington University School of Medicine, St Louis
Lead Sponsor
Millennium Pharmaceuticals, Inc.
INDUSTRY